Fintel reports that on November 15, 2024, B of A Securities downgraded their outlook for bluebird bio (MUN:BLE) from Buy to Neutral. As of December 21, 2023, the average one-year price target for ...
Fintel reports that on August 15, 2024, JP Morgan downgraded their outlook for bluebird bio (MUN:BLE) from Overweight to Neutral. As of December 21, 2023, the average one-year price target for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results